Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-02-03

FDA Approved: SEVELAMER HYDROCHLORIDE — Original Application (Zydus Pharmaceuticals USA Inc.)

View source ↗

Summary

FDA approves the original application for sevelamer hydrochloride (generic) by Zydus Pharmaceuticals USA Inc. for the treatment of hyperphosphatemia in patients…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Sevelamer hydrochloride (sevelamer hydrochloride)

Snippet

ORIG AP for SEVELAMER HYDROCHLORIDE (SEVELAMER HYDROCHLORIDE)